UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II study of S-1 and oxaliplatin as neo-adjuvant chemotherapy for locally advanced gastric and esophago-gastric cancer (KSCC1601)

Annals of oncology, 2018-10, Vol.29, p.viii225-viii226

2018

Volltextzugriff (PDF)

2137 Comparison of two Phase II trials of mFOLFOX6 plus bevacizumab (KSCC0802) and SOX (S-1 and oxaliplatin) plus cetuximab (KSCC1002): First line chemotherapy in colorectal cancer patients with initially unresectable or not optimally resectable liver only metastases

European journal of cancer (1990), 2015-09, Vol.51, p.S378-S378

2015

Volltextzugriff (PDF)

Prospective multicenter trial of sentinel node mapping for gastric cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.4518-4518

2009

Volltextzugriff (PDF)

Abstract P4-09-06: No inverse association between breast cancer risk and n-3 unsaturated fatty acids in erythrocytes among Japanese women

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P4-P4-09-06

2013

Volltextzugriff (PDF)

Abstract 3264: Genome-wide shRNA screen identifies ITIH5 gene as a metastasis suppressor of pancreatic ductal adenocarcinoma (PDAC)

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3264-3264

2015

Volltextzugriff (PDF)

The Present Status of the Management of Colon and Rectal Cancer in Nigeria

Journal of Cancer Research, 2014-08, Vol.2014, p.1-7

2014

Volltextzugriff (PDF)

670PPhase II study of S-1 and oxaliplatin as neo-adjuvant chemotherapy for locally advanced gastric and esophago-gastric cancer (KSCC1601)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Clinical features of remnant pancreatic cancer following curative pancreas resection

HPB (Oxford, England), 2018-09, Vol.20, p.S584-S585

2018

Volltextzugriff (PDF)

Examination of conversion surgery for unresectable pancreatic cancer

HPB (Oxford, England), 2018-09, Vol.20, p.S586-S586

2018

Volltextzugriff (PDF)

A treatment strategy to elderly HCC is considered from the analysis of prognosis

HPB (Oxford, England), 2018-09, Vol.20, p.S376-S376

2018

Volltextzugriff (PDF)

Significance of neoadjuvant chemoradiotherapy for locally advanced pancreatic cancer

HPB (Oxford, England), 2018-09, Vol.20, p.S534-S534

2018

Volltextzugriff (PDF)

Complete gastric wrapping method for pancreaticogastrostomy using twin horizontal mattress sutures

HPB (Oxford, England), 2018-09, Vol.20, p.S655-S656

2018

Volltextzugriff (PDF)

Severe pancreatitis with colonic perforation successfully managed using video-assisted retroperitoneal debridement: a case report

HPB (Oxford, England), 2018-09, Vol.20, p.S523-S523

2018

Volltextzugriff (PDF)

Examination of pancreatic cystic neoplasm except IPMN who underwent surgical resection in our department

HPB (Oxford, England), 2018-09, Vol.20, p.S528-S528

2018

Volltextzugriff (PDF)

The expression of CD163+ and CD68+ macrophage in hepatocellular carcinoma

HPB (Oxford, England), 2018-09, Vol.20, p.S386-S386

2018

Volltextzugriff (PDF)

Simple and easy method to isolate main pancreatic duct during pancreatoduodenectomy

HPB (Oxford, England), 2018-09, Vol.20, p.S651-S651

2018

Volltextzugriff (PDF)

The Effect of Hydroxybenzoate Lithium Complexes in Inducing Apoptosis in HT-1080 Human Fibrosarcoma Cells

Journal of Cancer Research, 2013-08, Vol.2013 (2013), p.1-8

2013

Volltextzugriff (PDF)

Clinical features and treatment of patients with esophageal cancer and a history of gastrectomy: a multicenter, questionnaire survey in Kyushu, Japan: Esophageal cancer after gastrectomy

Diseases of the esophagus, 2016-11, Vol.29 (8), p.1135-1143

2016

Volltextzugriff (PDF)

Introduction

Nippon Kikan Shokudoka Gakkai kaiho, 2011, Vol.62 (2), p.136-136

2011

Volltextzugriff (PDF)

Phase II Study Alternating Mfolfox 6 and Folfiri (FIREFOX) Plus Bevacizumab (BEV) Regimen in First-Line Treatment of Advanced Colorectal Cancer in Japanese Patients (KSCC 0801)

Annals of oncology, 2012-10, Vol.23, p.xi130

2012

Volltextzugriff (PDF)

Phase II Study of Combination Therapy with S-1 and Cetuximab in Patients with Kras Wild-Type Unresectable Colorectal Cancer, who Had Previously Received Irinotecan, Oxaliplatin, and Fluoropyrimidines (KSCC0901)

Annals of oncology, 2012-10, Vol.23, p.xi122

2012

Volltextzugriff (PDF)

Analysis of oxaliplatin-induced sensory neurotoxicity (sNT) in patients receiving FIREFOX, alternating regimen of mFOLFOX-6 and FOLFIRI, with metastatic colorectal cancer (MCRC): Results from combined analysis of KSCC0501 and KSCC0701

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.492-492

2011

Volltextzugriff (PDF)

Adjuvant capecitabine treatment for stage III colon cancer in Japanese patients (KSCC0803)

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.571-571

2011

Volltextzugriff (PDF)

Liver Resectability Following MFOLFOX6 with Bevacizumab as the First-Line Treatment of Unresectable Liver Limited Metastases from Colorectal Cancer in Japanese Patients (KSCC 0802)

Annals of oncology, 2012-10, Vol.23, p.xi82-xi83

2012

Volltextzugriff (PDF)

A phase II trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent external-beam radiotherapy for locally advanced pancreatic cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e15570-e15570

2009

Volltextzugriff (PDF)

1 – 25 von 456

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(243)
Mit Volltextzugriff
(395)

Publikationsform

Sprache

Englisch
(379)
Japanisch
(108)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase II study of S-1 and oxaliplatin as neo-adjuvant chemotherapy for locally advanced gastric and esophago-gastric cancer (KSCC1601)

2137 Comparison of two Phase II trials of mFOLFOX6 plus bevacizumab (KSCC0802) and SOX (S-1 and oxaliplatin) plus cetuximab (KSCC1002): First line chemotherapy in colorectal cancer patients with initially unresectable or not optimally resectable liver only metastases

Prospective multicenter trial of sentinel node mapping for gastric cancer

Abstract P4-09-06: No inverse association between breast cancer risk and n-3 unsaturated fatty acids in erythrocytes among Japanese women

Abstract 3264: Genome-wide shRNA screen identifies ITIH5 gene as a metastasis suppressor of pancreatic ductal adenocarcinoma (PDAC)

The Present Status of the Management of Colon and Rectal Cancer in Nigeria

670PPhase II study of S-1 and oxaliplatin as neo-adjuvant chemotherapy for locally advanced gastric and esophago-gastric cancer (KSCC1601)

Clinical features of remnant pancreatic cancer following curative pancreas resection

Examination of conversion surgery for unresectable pancreatic cancer

A treatment strategy to elderly HCC is considered from the analysis of prognosis

Significance of neoadjuvant chemoradiotherapy for locally advanced pancreatic cancer

Complete gastric wrapping method for pancreaticogastrostomy using twin horizontal mattress sutures

Severe pancreatitis with colonic perforation successfully managed using video-assisted retroperitoneal debridement: a case report

Examination of pancreatic cystic neoplasm except IPMN who underwent surgical resection in our department

The expression of CD163+ and CD68+ macrophage in hepatocellular carcinoma

Simple and easy method to isolate main pancreatic duct during pancreatoduodenectomy

The Effect of Hydroxybenzoate Lithium Complexes in Inducing Apoptosis in HT-1080 Human Fibrosarcoma Cells

Clinical features and treatment of patients with esophageal cancer and a history of gastrectomy: a multicenter, questionnaire survey in Kyushu, Japan: Esophageal cancer after gastrectomy

Introduction

Phase II Study Alternating Mfolfox 6 and Folfiri (FIREFOX) Plus Bevacizumab (BEV) Regimen in First-Line Treatment of Advanced Colorectal Cancer in Japanese Patients (KSCC 0801)

Phase II Study of Combination Therapy with S-1 and Cetuximab in Patients with Kras Wild-Type Unresectable Colorectal Cancer, who Had Previously Received Irinotecan, Oxaliplatin, and Fluoropyrimidines (KSCC0901)

Analysis of oxaliplatin-induced sensory neurotoxicity (sNT) in patients receiving FIREFOX, alternating regimen of mFOLFOX-6 and FOLFIRI, with metastatic colorectal cancer (MCRC): Results from combined analysis of KSCC0501 and KSCC0701

Adjuvant capecitabine treatment for stage III colon cancer in Japanese patients (KSCC0803)

Liver Resectability Following MFOLFOX6 with Bevacizumab as the First-Line Treatment of Unresectable Liver Limited Metastases from Colorectal Cancer in Japanese Patients (KSCC 0802)

A phase II trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent external-beam radiotherapy for locally advanced pancreatic cancer

Aktive Filter

Suchergebnisse filtern